# ARANESP

NDC: 55513-032
Generic name: darbepoetin alfa
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20060607

FDA application: BLA103951

## Active ingredients

- DARBEPOETIN ALFA: 500 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-032"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-032
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fd36cb9-c4f6-4167-93c9-8530865db3f9